A Case of Severe Coronary Spasm Associated with 5-Fluorouracil Chemotherapy |
Kim, Sang-Min
(Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Kwak, Cheol-Hoon (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital) Lee, Bo-Ra (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital) Kim, Seong-Beom (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital) Sir, Jung-Ju (Department of Internal Medicine, Cardiovascular Center, National Medical Center) Cho, Wook-Hyun (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital) Choi, Suk-Koo (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital) |
1 | Jensen SA, Sorensen JB. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol 2006;58:487-493. DOI ScienceOn |
2 | Wacker A, Lersch C, Scherpinski U, Reindl L, Seyfarth M. High incidence of angina pectoris in patients treated with 5-fluorouracil: a planned surveillance study with 102 patients. Oncology 2003;65:108-112. DOI ScienceOn |
3 | Robben NC, P ippa s AW, Moore JO. The sy nd rome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy. Cancer 1993;71:493-509. DOI ScienceOn |
4 | Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-f luorouracil alone or in combination with cisplatin. Cancer 1990;65:885-889. DOI ScienceOn |
5 | Gradishar WJ, Vokes EE. 5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol 1990;1:409-414. DOI |
6 | Rezkalla S, Kloner RA, Ensley J, et al. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989;7:509-514. DOI |
7 | Kleiman NS, Lehane DE, Geyer CE Jr, Pratt CM, Young JB. Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med 1987;82:566-568. DOI ScienceOn |
8 | Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J, Wynne J. 5-fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 1987;294:238-243. DOI ScienceOn |
9 | Baker WP, Dainer P, Lester WM, Marty AM, Blair TP. Ischemic chest pain after 5-fluorouracil therapy for cancer. Am J Cardiol 1986;57:497-498. DOI ScienceOn |
10 | Meydan N, Kundak I, Yavuzsen T, et al. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and longterm follow-up. Jpn J Clin Oncol 2005;35:265-270. DOI ScienceOn |
![]() |